Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study.
Colafrancesco S, Priori R, Valesini G, Argolini L, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Cantarini L, Cavallaro E, Cavalli G, Cerrito L, Cipriani P, Dagna L, Marchi G, Vita S, Emmi G, Ferraccioli G, Frassi M, Galeazzi M, Gerli R, Giacomelli R, Gremese E, Iannone F, Lapadula G, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Ruscitti P, Silvestri E, Stagnaro C, Talarico R, Tincani A, Viapiana O, Vitiello G, Fabris F, Bindoli S, Punzi L, Galozzi P, Sfriso P. Colafrancesco S, et al. Among authors: gremese e. Front Pharmacol. 2017 Jun 13;8:369. doi: 10.3389/fphar.2017.00369. eCollection 2017. Front Pharmacol. 2017. PMID: 28659802 Free PMC article.
Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years.
Ferraccioli GF, Gremese E, Tomietto P, Favret G, Damato R, Di Poi E. Ferraccioli GF, et al. Among authors: gremese e. Rheumatology (Oxford). 2002 Aug;41(8):892-8. doi: 10.1093/rheumatology/41.8.892. Rheumatology (Oxford). 2002. PMID: 12154206 Clinical Trial.
Hepatocyte growth factor and transforming growth factor beta1 ratio at baseline can predict early response to cyclophosphamide in systemic lupus erythematosus nephritis.
Capuano A, Costanzi S, Peluso G, Zannoni G, Vellone VG, Gremese E, Zoli A, Scott C, Beltrami CA, Romano G, Ferraccioli G. Capuano A, et al. Among authors: gremese e. Arthritis Rheum. 2006 Nov;54(11):3633-9. doi: 10.1002/art.22192. Arthritis Rheum. 2006. PMID: 17075808 Free article. Clinical Trial.
292 results